We are live on
!
Find out more
VEA
Virtus ETF Advisers Portfolio holdings
AUM
$215M
1-Year Est. Return
53.68%
This Fund
S&P 500
This Quarter
Est. Return
+9.34%
1 Year Est. Return
+53.68%
3 Year Est. Return
+121.72%
5 Year Est. Return
+144.54%
10 Year Est. Return
+633.35%
AUM
$612M
AUM Growth
+$115M
(+23%)
Cap. Flow
+$88.3M
Cap. Flow
% of AUM
14.44%
Top 10 Holdings %
Top 10 Hldgs %
8.98%
Holding
532
New
97
Increased
238
Reduced
88
Closed
80
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Telecom Argentina
TEO
|
+$2.03M |
| 2 |
Methanex
MEOH
|
+$1.43M |
| 3 |
EQM
EQM Midstream Partners, LP
EQM
|
+$1.32M |
| 4 |
Carlyle Secured Lending
CGBD
|
+$1.31M |
| 5 |
The GEO Group
GEO
|
+$1.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Oxford Square Capital
OXSQ
|
+$2.73M |
| 2 |
MPLX
MPLX
|
+$1.51M |
| 3 |
MDCO
Medicines Co
MDCO
|
+$982K |
| 4 |
Gladstone Investment Corp
GAIN
|
+$857K |
| 5 |
CELG
Celgene Corp
CELG
|
+$712K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 20.46% |
| 2 | Real Estate | 16.88% |
| 3 | Energy | 14.34% |
| 4 | Healthcare | 10.85% |
| 5 | Materials | 9.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
Fomento Económico Mexicano
FMX
$44B
| $47K | 0.01% |
502
+98
| +24% | +$9.01K |
|
302
Thermo Fisher Scientific
TMO
$210B
| $44K | 0.01% |
+135
| New | +$40.9K |
|
303
Cigna
CI
$76.7B
| $43K | 0.01% |
208
+15
| +8% | +$2.75K |
|
304
Itaú Unibanco
ITUB
$92.4B
| $43K | 0.01% |
6,466
-812
| -11% | -$5.09K |
|
305
Citigroup
C
$223B
| $42K | 0.01% |
+528
| New | +$39K |
|
|
AINC
306
DELISTED
Ashford Inc.
AINC
| $41K | 0.01% |
+1,755
| New | +$41.8K |
|
307
Warner Bros
WBD
$64.3B
| $40K | 0.01% |
+1,218
| New | +$36.7K |
|
308
Accenture
ACN
$93.9B
| $37K | 0.01% |
+177
| New | +$34.5K |
|
309
Honeywell
HON
$77.8B
| $35K | 0.01% |
207
| – | – |
|
310
Banco Bradesco
BBD
$38.5B
| $34K | 0.01% |
5,017
-855
| -15% | -$5.35K |
|
311
Petrobras Class A
PBR.A
$105B
| $34K | 0.01% |
2,274
-314
| -12% | -$4.45K |
|
312
AbbVie
ABBV
$460B
| $33K | 0.01% |
+378
| New | +$31.4K |
|
313
Progressive
PGR
$125B
| $33K | 0.01% |
453
-60
| -12% | -$4.33K |
|
314
CME Group
CME
$92.4B
| $32K | 0.01% |
+159
| New | +$32.6K |
|
|
FISV
315
Fiserv Inc
FISV
$27.8B
| $32K | 0.01% |
+274
| New | +$30.3K |
|
316
Fidelity National Information Services
FIS
$22.1B
| $32K | 0.01% |
232
+63
| +37% | +$8.45K |
|
317
Johnson & Johnson
JNJ
$644B
| $32K | 0.01% |
218
+40
| +22% | +$5.42K |
|
318
S&P Global
SPGI
$129B
| $32K | 0.01% |
+117
| New | +$30.4K |
|
319
Capital One
COF
$127B
| $31K | 0.01% |
304
| – | – |
|
320
Intuit
INTU
$83.6B
| $31K | 0.01% |
+118
| New | +$30.9K |
|
321
Intuitive Surgical
ISRG
$127B
| $31K | 0.01% |
+159
| New | +$29.8K |
|
322
Globe Life
GL
$13.6B
| $30K | ﹤0.01% |
288
-67
| -19% | -$6.68K |
|
|
DFS
323
DELISTED
Discover Financial Services
DFS
| $29K | ﹤0.01% |
344
| – | – |
|
324
Global Payments
GPN
$22.5B
| $29K | ﹤0.01% |
+157
| New | +$26.9K |
|
325
ServiceNow
NOW
$106B
| $29K | ﹤0.01% |
+505
| New | +$26.6K |
|
Similar funds
NCM
SSA
LIWM
VFG
IAM
1M
GC
ALS
Virtus ETF Advisers's Q4 2019 Portfolio in Review
As of Q4 2019, Virtus ETF Advisers held 532 positions worth $612M, up 23% from $496M the previous quarter. Its ten largest holdings account for 9% of the portfolio.
Virtus ETF Advisers deployed $88.3M of net new capital in Q4 2019, opening 97 new positions and adding to 238 existing holdings. Its largest new stake was Odonate Therapeutics, Inc. Common Stock: 14,229 shares worth $462K.
By sector, the portfolio is most concentrated in Financials at 20% of assets, down from 24% a quarter earlier, followed by Real Estate and Energy.
On the sell side, the largest reduction was Oxford Square Capital, an estimated $2.73M trimmed.
- Virtus ETF Advisers's largest Q4 2019 buy was Odonate Therapeutics, Inc. Common Stock: 14,229 shares worth $462K.
- Virtus ETF Advisers added most to Telecom Argentina in Q4 2019, an estimated $2.03M increase.
- Virtus ETF Advisers's biggest Q4 2019 reduction was Oxford Square Capital, cutting an estimated $2.73M.
- Virtus ETF Advisers fully exited Medicines Co in Q4 2019, selling an estimated $982K.
- Virtus ETF Advisers's ten largest holdings make up 9% of its $612M portfolio in Q4 2019.
- Virtus ETF Advisers opened 97 new positions and closed 80 in Q4 2019.
- Virtus ETF Advisers's portfolio value rose 23% quarter-over-quarter to $612M.
Based on Virtus ETF Advisers's 13F filing for Q4 2019, filed 13 Feb 2020.